ARCHIVES

Reviewers Note Major Flaws In Design Of Burzynski’s Trials

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Study Finds Long-Term Remission In NHL With Tositumomab, Iodine I 131 With CHOP

December 30, 2005

OAM Advisor’s Faxes Promote Alternatives, Cassileth Writes To NIH

September 3, 1993

Harold Varmus Plans To Leave Presidency Of MSKCC

January 15, 2010

In Brief: NCI Providing Information On Levamisole To Patients; Macdonald Jins Temple, Salick

July 21, 1989

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

January 2, 1981